Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AF1517 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Goat Polyclonal ULBP-3 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified. Detects human ULBP-3 in direct ELISAs and Western blots. In these formats, approximately 5% cross-reactivity with recombinant human (rh) ULBP-2 is observed and less than 1% cross-reactivity with rhULBP-1 is observed.
- Reactivity
- Human
- Host
- Goat
- Isotype
- IgG
- Vial size
- 100 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Submitted references Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma.
Natural Killer Cell Evasion Is Essential for Infection by Rhesus Cytomegalovirus.
Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.
Immunohistochemical validation and expression profiling of NKG2D ligands in a wide spectrum of human epithelial neoplasms.
The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells.
NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting.
Weil S, Memmer S, Lechner A, Huppert V, Giannattasio A, Becker T, Müller-Runte A, Lampe K, Beutner D, Quaas A, Schubert R, Herrmann E, Steinle A, Koehl U, Walter L, von Bergwelt-Baildon MS, Koch J
Frontiers in immunology 2017;8:387
Frontiers in immunology 2017;8:387
Natural Killer Cell Evasion Is Essential for Infection by Rhesus Cytomegalovirus.
Sturgill ER, Malouli D, Hansen SG, Burwitz BJ, Seo S, Schneider CL, Womack JL, Verweij MC, Ventura AB, Bhusari A, Jeffries KM, Legasse AW, Axthelm MK, Hudson AW, Sacha JB, Picker LJ, Früh K
PLoS pathogens 2016 Aug;12(8):e1005868
PLoS pathogens 2016 Aug;12(8):e1005868
Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.
Giannattasio A, Weil S, Kloess S, Ansari N, Stelzer EH, Cerwenka A, Steinle A, Koehl U, Koch J
BMC cancer 2015 May 3;15:351
BMC cancer 2015 May 3;15:351
Immunohistochemical validation and expression profiling of NKG2D ligands in a wide spectrum of human epithelial neoplasms.
Fujita H, Hatanaka Y, Sutoh Y, Suzuki Y, Oba K, Hatanaka KC, Mitsuhashi T, Otsuka N, Fugo K, Kasahara M, Matsuno Y
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2015 Mar;63(3):217-27
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2015 Mar;63(3):217-27
The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells.
Fernández-Messina L, Ashiru O, Agüera-González S, Reyburn HT, Valés-Gómez M
Journal of cell science 2011 Feb 1;124(Pt 3):321-7
Journal of cell science 2011 Feb 1;124(Pt 3):321-7
NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting.
McGilvray RW, Eagle RA, Watson NF, Al-Attar A, Ball G, Jafferji I, Trowsdale J, Durrant LG
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Nov 15;15(22):6993-7002
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Nov 15;15(22):6993-7002
No comments: Submit comment
No validations: Submit validation data